Delayed Diagnosis Seen in More Than One in Four Pediatric Patients With Malaria
Medically reviewed by Drugs.com
via HealthDayTHURSDAY, May 21, 2026 -- For pediatric patients with malaria presenting to hospitals in the United States, delayed diagnoses are common and are associated with increased risk of severe malaria, according to a study published online May 8 in Pediatrics.
Sesh Alexander Sundararaman, M.D., Ph.D., from the Children's Hospital of Philadelphia, and colleagues conducted a retrospective descriptive study of pediatric patients treated for malaria at nine hospitals in the United States from 2016 to 2023. Patient demographics, clinical outcomes, and risk factors for severe malaria were examined among 171 children included in the study.
The researchers found that most of the patients had traveled to West Africa to visit friends and relatives. The most common symptom recorded was fever (90 percent), and at least one abdominal symptom was reported by most patients (66 percent). Severe malaria was diagnosed in 32 percent of patients; there were no deaths. Twenty-six percent of patients had delayed diagnoses; they occurred at similar rates across all hospitals and were a risk factor for severe malaria.
"Children who come in and are suspected of having malaria essentially have fever, but they can also present with a wide range of symptoms," senior author Audrey R. Odom-John, M.D., Ph.D., also from the Children's Hospital of Philadelphia, said in a statement. "They can have cough, they can have tummy symptoms, they can have headache, they can have almost anything. That's why rapid and precise testing is necessary to confirm these cases."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-22 09:54
Read more
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Number of Water Bead Ingestions Jumped in Young Children in Recent Years
- FDA Approves Immgolis Intri (golimumab-sldi), an Interchangeable Biosimilar to Simponi Aria (golimumab)
- DDW: Duodenal Mucosal Resurfacing Prevents Weight Regain After Tirzepatide Withdrawal
- ATS: Tezepelumab Reduces Asthma Exacerbations Across Asthma Phenotypes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions